ncRNA name
ROR
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
miR-145/FSCN1
Cancer name
Lung Adenocarcinoma
Cancer site
Lung
Treatment type
Chemotherapy
Drug
Docetaxel
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Our findings revealed that linc-ROR might act as potential therapeutic target to overcome chemotherapy resistance in LAD.
Tissue resource
human lung adenocarcinoma cell lines SPC-A1
human lung adenocarcinoma cell lines H1299
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Tumor Cell Bank of Chinese Academy of Medical Science
Country
China
Continent
Asia